Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Burkholderia pseudomallei Infection

beta-lactams has been researched along with Burkholderia pseudomallei Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McLaughlin, HP; Sue, D1
Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M1
Engler, C; Harris, P; Norton, R1
Breitbach, K; Eske-Pogodda, K; Harmer, NJ; Norville, IH; Sarkar-Tyson, M; Steinmetz, I; Titball, RW1
Chau, PY; Cheung, TK; Ho, PL; Woo, PC; Yuen, KY1

Other Studies

5 other study(ies) available for beta-lactams and Burkholderia pseudomallei Infection

ArticleYear
Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
    BMC microbiology, 2018, 12-18, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Burkholderia mallei; Burkholderia pseudomallei; Ciprofloxacin; Doxycycline; Glanders; Humans; Imipenem; Melioidosis; Microbial Sensitivity Tests; Plague; Time-Lapse Imaging; Yersinia pestis

2018
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:6

    Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins

2011
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Burkholderia pseudomallei; Carbapenems; Doripenem; Ertapenem; Fluoroquinolones; Humans; Melioidosis; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline

2011
A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
    Microbiology (Reading, England), 2011, Volume: 157, Issue:Pt 9

    Topics: Amino Acid Sequence; Animals; Bacterial Proteins; beta-Lactams; Burkholderia pseudomallei; Disease Models, Animal; Enzyme Activation; Female; HeLa Cells; Humans; Melioidosis; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Peptidylprolyl Isomerase; Protein Conformation; Recombinant Proteins; Sequence Alignment; Tacrolimus Binding Proteins; Virulence

2011
Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Burkholderia pseudomallei; Cloning, Molecular; Gene Expression Regulation, Bacterial; Hong Kong; Humans; Kinetics; Melioidosis; Microbial Sensitivity Tests; Molecular Sequence Data; Soil Microbiology; Thailand

2002